Follow-up of CHD lesions: choose a lesion, answer each step, and the path lights up. Adapted from ACC.org expert analyses; some of their figures are reprinted from the 2026 ACC concise clinical guidance.
Judson Moore, MD; Mira Trivedi, MD; Shazia Samad Mohsin, MBBS, FACC; Dr. Clayton Allen Smith Jr., MD; Anitha Parthiban, MBBS, FACC; Sarah T Plummer, MD, FACC; Christopher Statile, MD, FACC; Ritu Sachdeva, MBBS, FACC; Shreya Sunil Sheth, MD, FACC. Clinical Practice Algorithm For the Follow-Up of Unrepaired and Repaired Tetralogy of Fallot. ACC.org Expert Analysis, originally published on Oct. 31, 2024, updated on April 12, 2026. https://www.acc.org/Latest-in-Cardiology/Articles/2024/10/30/13/20/Clinical-Practice-Algorithm-For-the-Follow-Up-of-Unrepaired-and-Repaired-ToF. The figures were read as images from the article's PDF (revised 2026).
Dr. Hayley S. Hancock, MD; Annette K. Ansong, MD, FACC; Danielle Massarella, MD; Shazia Samad Mohsin, MBBS, FACC; Anitha Parthiban, MBBS, FACC; Dr. Clayton Allen Smith Jr., MD; Christopher Statile, MD, FACC; Ali N. Zaidi, MD, FACC; Ritu Sachdeva, MBBS, FACC. Clinical Practice Algorithm For the Follow-Up of Unrepaired and Repaired Patent Ductus Arteriosus. ACC.org Expert Analysis, Aug 26, 2026. https://www.acc.org/Latest-in-Cardiology/Articles/2022/10/31/13/02/Clinical-Practice-Algorithm-For-the-Follow-Up-of-Unrepaired-and-Repaired-PDA. The figures were read as images. The page prints that one date; its address carries 2022/10/31.
Dr. Hayley S. Hancock, MD; Brian Birnbaum, MD, FACC; Aamisha Gupta, MD, FACC; Roni M. Jacobsen, MD, FACC; Alexander Sasha Opotowsky, MD, FACC; Christopher Statile, MD, FACC; Ali N. Zaidi, MD, FACC; Ritu Sachdeva, MBBS, FACC; Anitha Parthiban, MBBS, FACC; Sarah T Plummer, MD, FACC. Clinical Practice Algorithm For the Follow-Up of Patients With Fontan Circulation. ACC.org Expert Analysis, Apr 23, 2025. https://www.acc.org/Latest-in-Cardiology/Articles/2025/04/22/17/18/Clinical-Practice-Algorithm-For-the-Follow-Up-of-Patients-With-Fontan-Circulation. The figures were read as images from the article's PDF.
Writing Committee, Sachdeva R, Parthiban A, et al. Outpatient management of isolated left-to-right shunt lesions in pediatric patients: 2026 ACC concise clinical guidance: a report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol. Published online March 26, 2026. doi:10.1016/j.jacc.2025.11.020. The PDA, ASD, VSD and AVSD pages credit their figures to this document. The document itself has not been read for this page; nothing is said of its contents beyond what the ACC pages print.
What the PDA article also cites (not read here)
Sachdeva R, Valente AM, Armstrong AK, et al. ACC/AHA/ASE/HRS/ISACHD/SCAI/SCCT/SCMR/SOPE 2020 appropriate use criteria for multimodality imaging during the follow-up care of patients with congenital heart disease: a report of the American College of Cardiology Solution Set Oversight Committee and Appropriate Use Criteria Task Force, American Heart Association, American Society of Echocardiography, Heart Rhythm Society, International Society for Adult Congenital Heart Disease, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, and Society of Pediatric Echocardiography. J Am Coll Cardiol. 2020;75(6):657-703. doi:10.1016/j.jacc.2019.10.002
Feltes TF, Bacha E, Beekman RH 3rd, et al. Indications for cardiac catheterization and intervention in pediatric cardiac disease: a scientific statement from the American Heart Association. Circulation. 2011;123(22):2607-2652. doi:10.1161/CIR.0b013e31821b1f10
What the ToF figures cite (as printed with them, no DOIs; not read here). Before repair: 1 to 4. Post repair: 4 to 8.
Clarke NS, Thibault D, Alejo D, et al. Contemporary patterns of care in tetralogy of Fallot: analysis of the Society of Thoracic Surgeons data. Ann Thorac Surg 2023;116:768-75.
Goldmuntz E. 22q11.2 deletion syndrome and congenital heart disease. Am J Med Genet C Semin Med Genet 2020;184:64-72.
Peck D, Tretter J, Possner M, et al. Timing of repair in tetralogy of Fallot: effects on outcomes and myocardial health. Cardiol Rev 2021;29:62-7.
Miller JR, Stephens EH, Goldstone AB, et al.; Expert Consensus Panel. The American Association for Thoracic Surgery (AATS) 2022 expert consensus document: management of infants and neonates with tetralogy of Fallot. J Thorac Cardiovasc Surg 2023;165:221-50.
Baumgartner H, De Backer J, Babu-Narayan SV, et al.; ESC Scientific Document Group. 2020 ESC guidelines for the management of adult congenital heart disease. Eur Heart J 2021;42:563-645.
Geva T. Indications for pulmonary valve replacement in repaired tetralogy of fallot: the quest continues. Circulation 2013;128:1855-7.
Sachdeva R, Valente AM, Armstrong AK, et al. ACC/AHA/ASE/HRS/ISACHD/SCAI/SCCT/SCMR/SOPE 2020 appropriate use criteria for multimodality imaging during the follow-up care of patients with congenital heart disease: a report of the American College of Cardiology Solution Set Oversight Committee and Appropriate Use Criteria Task Force, American Heart Association, American Society of Echocardiography, Heart Rhythm Society, International Society for Adult Congenital Heart Disease, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, and Society of Pediatric Echocardiography. J Am Coll Cardiol 2020;75:657-703.
Stout KK, Daniels CJ, Aboulhosn JA, et al. 2018 AHA/ACC guideline for the management of adults with congenital heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol 2019;73:e81-e192.
Compared against, and read for our own pages
Nathan M, Kiskaddon AL, Emani S, et al. 2026 American Association for Thoracic Surgery (AATS) expert consensus statement: antithrombotic management of neonates/infants undergoing cardiac interventions. J Thorac Cardiovasc Surg 2026;172(3):618-662.e7. doi:10.1016/j.jtcvs.2026.03.617
Baumgartner H, Hung J, Bermejo J, et al. Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice. J Am Soc Echocardiogr 2009;22:1-23. doi:10.1016/j.echo.2008.11.029
Geva T, Wald RM, Bucholz E, et al.; AHA Council on Lifelong Congenital Heart Disease and Heart Health in the Young, et al. Long-term management of right ventricular outflow tract dysfunction in repaired tetralogy of Fallot: a scientific statement from the American Heart Association. Circulation 2024;150(25):e689-e707. doi:10.1161/CIR.0000000000001291
Nelson JS, Lu JC, Ashfaq A, et al. The Society of Thoracic Surgeons/World Society for Pediatric and Congenital Heart Surgery/European Congenital Heart Surgeons Association 2026 clinical practice guidelines on indications and timing of pulmonary valve replacement in repaired tetralogy of Fallot. Ann Thorac Surg 2026. doi:10.1016/j.athoracsur.2026.04.011
Gurvitz M, Krieger EV, Fuller S, et al. (Writing Committee). 2025 ACC/AHA/HRS/ISACHD/SCAI guideline for the management of adults with congenital heart disease. Circulation 2026;153(8):e115-e251 (also J Am Coll Cardiol, 10.1016/j.jacc.2025.09.006). doi:10.1161/CIR.0000000000001402
Baumgartner H, De Backer J, Babu-Narayan SV, et al. 2020 ESC Guidelines for the management of adult congenital heart disease. Eur Heart J 2021;42(6):563-645. doi:10.1093/eurheartj/ehaa554
How it was checked
The flowcharts are our own drawing and colours. Node text, branch labels, boxes and footnotes are the source's own words, read from the rendered figures. No answer is scored or calculated: the choices are the printed branch labels. An arrow printed with no label is offered as "(no label)", on a phone "Arrow with no printed label". The "No single branch printed for" choices, the notes marked No branch, Two branches apply, Ambiguous as printed, Not printed or As printed, the one-line exclusions on a phone, and the notes on what the article says are this site's words.
Other differences from Repaired Tetralogy of Fallot: RVESVi >80 here vs ≥80 mL/m² (Adult: STS 2026, ESC 2020). Without symptoms, ≥2 of 11 items here vs ≥2 of 5 (AHA 2024; Adult: ACHD 2025), ≥2 of 4 (Adult: STS 2026), any 1 of 4 (Adult: ESC 2020). Entry by echo grade here vs PR fraction ≥25% (AHA 2024; Adult: ACHD 2025, STS 2026). TR, AR and branch PA stenosis are graded by words here, by fractions and flows there (AHA 2024). Repeat CMR every 3-5 years here vs every 2-3 y with PR ≥moderate (Adult: ACHD 2025). RVSP >2/3 systemic (Adult: ACHD 2025). RVEF <47% and LVEF <55% agree with the adult rows of STS 2026 in value.
As printed. ToF: the criteria box "Consider asymptomatic valve replacement" has no arrow into the flow; it is drawn where the source draws it. On a phone it shows at Progressive RV dilation, Asymptomatic surveillance and the second PVR box. PDA: the article's Quick Takes give every 2-3 years for small PDAs and its Figure 1a every 1-2 y; the article's text says an audible PDA is referred for closure while Figure 1a sends a small audible PDA with no left heart dilation to a shared decision. Figures 1a and 1b are not joined by an arrow. VSD Figure 1a prints "dicharge"; this page spells it discharge. A slash in a VSD branch label marks a line break in the figure. VSD Figure 1b's "No†" line runs between the follow-up box and the Symptomatic diamond with its arrowhead at the diamond: drawn as printed, and not resolved here. AVSD Figure 1a's "LV or RV dilation; Qp:Qs >1.5:1" has one arrow with no label: drawn as printed, and not resolved here. PS: the 3 on Consider Intervention is the figure's own reference number (Devanagondi 2017).
On a phone, the printed boxes before the first question sit in one closed row. What changes care at that visit stays open beside it, in the figure's words: 22q11 testing (ToF before repair), endocarditis prophylaxis and pulmonary vascular disease (AVSD repaired), routine visits (CoA 1-18 y), and cerebral aneurysm screening, the ABPM definition and the follow-up schedule (CoA ≥18 y).